Technology Prognosis

tracking technologies before you have to make a decision

Lucemyra (Lofexidine)

May 18, 2018

Lofexidine is an oral alpha-2 adrenergic agonist for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. Lucemyra is the first non-opiod drug indicated to alleviate symptoms of opioid withdrawal.